Skip to main content
Mark Walshauser, MD, Oncology, Decatur, IL, HSHS St. Elizabeth's Hospital

MarkAndrewWalshauserMD

Oncology Decatur, IL

Physician at Cancer Care Specialists of Illinois; Medical Director of Oncology St. Elizabeth's (HSHS) Belleville

Dr. Walshauser is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Walshauser's full profile

Already have an account?

Education & Training

  • Loyola University Medical Center
    Loyola University Medical CenterFellowship, Hematology and Medical Oncology, 2011 - 2014
  • St Louis University School of Medicine
    St Louis University School of MedicineChief Residency, Internal Medicine, 2010 - 2011
  • St Louis University School of Medicine
    St Louis University School of MedicineResidency, Internal Medicine, 2008 - 2010
  • St Louis University School of Medicine
    St Louis University School of MedicineInternship, Internal Medicine, 2007 - 2008
  • Ross University School of Medicine
    Ross University School of MedicineClass of 2006, Doctor of Medicine, Magna Cum Laude
  • Cleveland College
    Cleveland CollegeBS, 2001 - 2002

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2011 - 2026
  • MO State Medical License
    MO State Medical License 2010 - 2015
  • WI State Medical License
    WI State Medical License 2009 - 2011

Awards, Honors, & Recognition

  • Intern of the Year Saint Louis University, Department of Internal Medicine, 2007
  • Dean’s list Ross University (2003-2006), 2006
  • First place ACP Maryland chapter clinical vignette resident abstract contest, 2005
  • Join now to see all

Publications & Presentations

PubMed

Abstracts/Posters

  • Reduction of Hspa9 Expression, a Del(5q) Candidate Gene, in a Murine Bone Marrow Transplantation Model Recapitulates Key Features of Ineffective Hematopoiesis Observed...
    Chen T, Kambal A, Walshauser M, Raju G, Walter M, Blood, Vol, 114, NO 22
  • Reduced HSPA9B expression, a 5q31.2 candidate gene, in primary human CD34+ cells recapitulates features of ineffective hematopoiesis observed in MDS.
    Chen TH, Walshauser MA, Kambal A, Raju G, Walter MJ, Blood, Vol, 110, iss11

Lectures

  • The transcription factor POU4F1 is a downstream target of AML/ETO in patients with t(8:21) AML. 
    Siteman Cancer Center hematopoietic stem cell research day. St. Louis, MO
  • Identification of Myelodysplastic Syndrome candidate genes on chromosome 5q31.2. 
    Siteman Cancer Center hematopoietic stem cell research day. St. Louis, MO
  • Speedball blindness, quinine toxicity in IVDA. 
    Maryland ACP annual meeting. Baltimore, MD

Other

  • Neurosarciodosis in a Patient Presenting with Ataxia, Headache, and Confusion. 
    Mohsen G, Walshauser M
    Osage Beach, MO
  • Liver vs. Muscles, Are Anabolic Steroids Worth the Risk? 
    Chala E, Walshauser M, Befler A
    Osage Beach, MO
  • A Rare Case of Phenytoin Induced Rhabdomyolysis. 
    Bhatti F, Walshauser M
    Osage Beach, MO
  • Join now to see all

Authored Content

  • Driving Culture Change in the Pursuit of Oncology ValueJuly 2020
  • Driving Culture Change in the Pursuit of Oncology ValueJuly 2020

Press Mentions

  • Cancer Care Specialists of Illinois and HSHS St. Elizabeth’s Hospital Hold Ceremonial Groundbreaking for a New Cancer Care Center
    Cancer Care Specialists of Illinois and HSHS St. Elizabeth’s Hospital Hold Ceremonial Groundbreaking for a New Cancer Care CenterApril 18th, 2019

Committees

  • Member, American Society of Hematology Trainee Council Member 2012 - 2014

Professional Memberships

Hospital Affiliations